Posts about "alpha-synuclein"

Scientists have achieved a major breakthrough by directly imaging and measuring protein clusters in the human brain believed to trigger Parkinson’s disease, a discovery that marks a significant step in understanding and potentially treating the disorder.

In a groundbreaking study, scientists have developed a new peptide that prevents the clumping of the alpha-synuclein protein, a hallmark of Parkinson's disease. This innovation, a collaborative effort from the University of Bath, Oxford, and Bristol, offers new hope for Parkinson's treatment.